Treating patients with ALK-rearranged non-small-cell lung cancer: mechanisms of resistance and strategies to overcome it. [electronic resource]
- Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico Jun 2017
- 658-666 p. digital
Publication Type: Journal Article; Review
1699-3055
10.1007/s12094-016-1605-y doi
Anaplastic Lymphoma Kinase Antineoplastic Agents--therapeutic use Carcinoma, Non-Small-Cell Lung--drug therapy Drug Resistance, Neoplasm--physiology Gene Rearrangement Humans Lung Neoplasms--drug therapy Protein Kinase Inhibitors--therapeutic use Receptor Protein-Tyrosine Kinases--genetics